Skinuva™ Scar, Founded By Beverly Hills Based Dr. Christopher Zoumalan, is a next-generation new scar cream that is the first to use highly selective growth factors in its unique formulation.

Skinuva™ Scar is a next-generation new scar cream that is the first of its kind to use highly selective growth factors in its unique formulation. It is arguably the most advanced scar cream formulated, where clinical studies have shown that it performed two times better than regular silicone cream. Skinuva™ Scar (http://www.skinuva.com) was developed and formulated by Dr. Christopher Zoumalan, a board-certified Beverly Hills Oculoplastic surgeon and his team of chemists and scientists. Skinuva™ Scar has been clinically applied on thousands of scars, and clinically tested in hundreds of patients who have seen incredible improvements in the appearance of their scars.

Skinuva™ Scar continues to provide cutting edge clinical research by a recent publication in Journal of Drugs and Dermatology. A Skinuva™ Scar clinical study was recently published in JDD showing that scars that were treated with Skinuva healed better and required less need for other additional treatments such as steroids, which can be alternative or adjunct options in scar management.

“This clinical study gives me and my colleagues even more reason to consider using Skinuva™ Scar, since it allows the scar to heal incredibly well and require less additional treatments that the scar may require,” says founder of Skinuva™ and principal investigator of the study, Dr. Christopher Zoumalan. He continues by saying “there has been a significant lack of advancements in the topical scar cream market over the past 15-20 years. Not much has been added to topical scar creams besides differing formulations of silicone creams and gels, and Skinuva is the first to provide clinical studies to show that it heals scars better than silicone cream.”

Backed by other clinical studies, a double-blind, randomized, multi-center clinical trial was published in the Aesthetic Surgery Journal this past February 2019, where Skinuva was shown to outperform silicone cream nearly two-fold when it came to the appearance of scars in various clinical parameters, including vascularity, pigmentation, pliability, and thickness.

Some of the highlights in Skinuva’s performance are:

  • Softens and flattens the appearance of scars
  • Reduces the appearance of redness and discoloration
  • Relieves itch and discomfort associated with dryness
  • Sunscreen may be worn over
  • Gentle for all skin types
  • No dyes, oils or parabens

Skinuva™ Scar is currently available to doctors and consumers. To place an order, please visit http://www.skinuva.com.

Originally published on PRWEB